Infervision is a leading high-tech AI healthcare company dedicated to revolutionizing the field of AI medicine. With a strong belief in Building a Shared Destiny for Humankind with AI, Infervision focuses on developing comprehensive medical AI platforms using deep learning technology. These platforms include AI deployment and management platforms, AI big data mining research platforms, and AI clinical application platforms.

Infervision aims to create medical AI solutions for quality control, health management, and innovative research. Established in 2016, Infervision has strategically positioned itself as a global AI brand by providing multidimensional product lines covering major diseases in various organs such as the lungs, cardiovascular system, breast, and joints. As one of the few AI healthcare companies that have obtained market access approvals from FDA, CE, PMDA, and NMPA, Infervision's products are trusted by over 500 medical institutions in nearly 20 countries worldwide.

Infervision offers integrated smart healthcare services to governments, medical institutions, doctors, and patients, striving to improve human life through the power of AI